Nischarin has been suggested to be involved in the inhibition of tumor cell growth via upregulation of the expression of the α5 subunit, reducing the phosphorylation of focal adhesion protein tyrosine kinase and decreasing the Rac GTP load (26). This evidence concerns the gene AKT1 and neoplasm.